These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 21794790
1. [Descriptive study of the use of DMARD in patients with rheumatoid arthritis or persistent arthritis who start drug treatment in Spain (FIRST)]. Blanco FJ, Ballina J, Carbonell J, Martín-Mola E, Tornero J, Ramírez E, Galván J. Reumatol Clin; 2011; 7(2):88-93. PubMed ID: 21794790 [Abstract] [Full Text] [Related]
2. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients. Sokka T, Pincus T. J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145 [Abstract] [Full Text] [Related]
3. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry. Weaver AL, Lautzenheiser RL, Schiff MH, Gibofsky A, Perruquet JL, Luetkemeyer J, Paulus HE, Xia HA, Leff JA, RADIUS Investigators. Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444 [Abstract] [Full Text] [Related]
4. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Schmajuk G, Schneeweiss S, Katz JN, Weinblatt ME, Setoguchi S, Avorn J, Levin R, Solomon DH. Arthritis Rheum; 2007 Aug 15; 57(6):928-34. PubMed ID: 17665462 [Abstract] [Full Text] [Related]
5. Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience. Cardiel MH, Pons-Estel BA, Sacnun MP, Wojdyla D, Saurit V, Marcos JC, Pinto MR, Cordeiro de Azevedo AB, da Silveira IG, Radominski SC, Ximenes AC, Massardo L, Ballesteros F, Rojas-Villarraga A, Oñate RV, Hernandez MP, Esquivel-Valerio JA, García-De La Torre I, Khoury VJ, Millán A, Soriano ER, GLADAR. J Clin Rheumatol; 2012 Oct 15; 18(7):327-35. PubMed ID: 23047532 [Abstract] [Full Text] [Related]
10. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T, FIN-RACo Trial Group. Arthritis Rheum; 2009 May 15; 60(5):1222-31. PubMed ID: 19404945 [Abstract] [Full Text] [Related]
15. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists. Zink A, Listing J, Ziemer S, Zeidler H, German Collaborative Arthritis Centres. J Rheumatol; 2001 Oct 15; 28(10):2201-8. PubMed ID: 11669156 [Abstract] [Full Text] [Related]
16. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists. van Roon EN, van den Bemt PM, Jansen TL, Houtman NM, van de Laar MA, Brouwers JR. Clin Ther; 2009 Aug 15; 31(8):1737-46. PubMed ID: 19808132 [Abstract] [Full Text] [Related]